A carregar...

Suppression of Renal Cell Carcinoma Growth and Metastasis with Sustained Antiangiogenic Gene Therapy

Renal cell carcinoma (RCC) is the third most common urologic neoplasm. This aggressive malignancy has proven refractory to conventional treatment options. Antiangiogenic agents have shown early success in treating metastatic disease. The highly vascular nature of RCC appears particularly susceptible...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: MELLON, MATTHEW J., BAE, KYUNG-HEE, STEDING, CATHERINE E., JIMÉNEZ, JUAN A., KAO, CHINGHAI, GARDNER, THOMAS A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2733371/
https://ncbi.nlm.nih.gov/pubmed/18507514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2007.135
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!